Analysis of predictive factors influencing dupilumab continuation rate in adult patients with atopic dermatitis: results from an Italian multicenter study.
Gori N, Sernicola A, Tolino E, Mariano M, Galluzzo M, Moretta G, Coppola R, D'Alessio A, Sansone M, Maffei V, Paolino C, Ferrao C, Cascia L, Addio P, Di Nardo L, Chiricozzi A, Del Duca E, Cristaudo A, Bianchi L, Pallotta S, Panasiti V, Pellacani G, Potenza C, Peris K.
Gori N, et al. Among authors: del duca e.
J Dermatolog Treat. 2023 Dec;34(1):2230685. doi: 10.1080/09546634.2023.2230685.
J Dermatolog Treat. 2023.
PMID: 37400981
Free article.